A carregar...
Possible Biomarkers for Cancer Immunotherapy
Immune checkpoint inhibitors (ICIs) have drastically changed the clinical care of cancer. Although cancer immunotherapy has shown promise in various types of malignancies, thus far, the proportion of patients who can benefit from ICIs is relatively small. Immune-related adverse events and high cost...
Na minha lista:
| Publicado no: | Cancers (Basel) |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
MDPI
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6678720/ https://ncbi.nlm.nih.gov/pubmed/31277279 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers11070935 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|